4.7 Article

Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome

Journal

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 24, Issue 10, Pages 1689-1697

Publisher

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2012121200

Keywords

-

Funding

  1. Roche Pharma AG (Grenzach, Germany)
  2. Novartis Pharma (Germany)
  3. Teva Pharma AG (Basel, Switzerland)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available